propiolactone has been researched along with HIV Coinfection in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lewis, AM; Peden, K; Sheng-Fowler, L | 1 |
| Agbarakwe, AE; Chapel, HM; Griffiths, H; Misbah, SA | 1 |
| Brackmann, HH; Kaiser, R; Kupfer, B; Matz, B; Oldenburg, J; Schneweis, KE | 1 |
| Horowitz, B | 1 |
| Bailly, E; Brackmann, HH; Hammerstein, U; Hanfland, P; Kleim, JP; Oldenburg, J; Schneweis, KE; van Loo, B | 1 |
1 review(s) available for propiolactone and HIV Coinfection
| Article | Year |
|---|---|
Inactivation of viruses found with plasma proteins.
Topics: Blood; Blood Proteins; Detergents; Freeze Drying; Hepatitis, Viral, Human; HIV Infections; Hot Temperature; Humans; Organophosphates; Propiolactone; Risk; Safety; Transfusion Reaction; Ultraviolet Rays; Virus Diseases; Viruses | 1991 |
4 other study(ies) available for propiolactone and HIV Coinfection
| Article | Year |
|---|---|
Quantitative determination of the infectivity of the proviral DNA of a retrovirus in vitro: Evaluation of methods for DNA inactivation.
Topics: AIDS Vaccines; Cells, Cultured; Cloning, Molecular; Disinfectants; DNA, Superhelical; DNA, Viral; Endodeoxyribonucleases; Endoribonucleases; HIV Infections; HIV-1; Humans; Jurkat Cells; Propiolactone; Retroviridae; Retroviridae Infections; Virus Inactivation | 2009 |
Effect of beta propiolactone on specific antibody measurements by ELISA.
Topics: Antibodies, Bacterial; Bacterial Capsules; Bacterial Vaccines; Diphtheria Toxoid; Enzyme-Linked Immunosorbent Assay; Haemophilus Vaccines; HIV Infections; Humans; Pneumococcal Vaccines; Polysaccharides, Bacterial; Propiolactone; Tetanus Toxoid | 1993 |
Beta-propiolactone UV inactivated clotting factor concentrate is the source of HIV-infection of 8 hemophilia B patients: confirmed.
Topics: Base Sequence; Blood Coagulation Factors; Hemophilia B; HIV Infections; Humans; Molecular Sequence Data; Propiolactone | 1995 |
Acute HIV-1 infection in patients with hemophilia B treated with beta-propiolactone-UV-inactivated clotting factor.
Topics: Blood Coagulation Factors; Drug Contamination; Gene Products, gag; Hemophilia B; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Propiolactone; Ultraviolet Rays; Viral Core Proteins | 1990 |